x

Search for a clinical trial

* (*) mandatory field

219 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
Ixazomib in combination to thalidomide - dexamethasone for patients with relapsed and/or refractory multiple myeloma (phase II) - AT
Wilhelminenspital
1. Medizinische Abteilung - Zentrum für Onkologie und Hämatologie

FRANCE

HAUTS-DE-FRANCE
AMIENS

Ongoing trial
Treatment of primary plasma cell leukemia of subjects under 70 years.
CHU Amiens-Picardie - Site Sud
Service d'Hématologie clinique et Thérapie cellulaire

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
ENDEAVOR: A Randomized, Open-label, Phase 3 Study of Carfilzomib Plus Dexamethasone Versus Bortezomib Plus Dexamethasone in Patients With Relapsed Multiple Myeloma - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
GMMG-HD6: A Randomized Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
A Randomized Phase 2 Trial to Evaluate Three Daratumumab Dose Schedules in Smoldering Multiple Myeloma - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
PESPECTIVE: Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE in RelapSed Myeloma Plus rEsponse Adapted Cyclophosphamide as a Tailored InnoVativE Strategy
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

GERMANY

Bayern
WÜRZBURG

DSMM VII: Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients with Relapsed or Refractory Multiple Myeloma (Phase II) - DE
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik II - Hämatologie und Onkologie

GERMANY

Bayern
WÜRZBURG

GERMANY

Hamburg
HAMBURG

Recruiting trial
Ongoing trial
Dose-finding study of Lenalidomide as maintenance therapy in Multiple Myeloma after Allogeneic Stem Cell Transplantation (Phase I/II)
UKE - Universitätsklinikum Hamburg-Eppendorf
Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation

GERMANY

Sachsen
ZWICKAU

GERMANY

Schleswig-Holstein
KIEL

ITALY

LAZIO
ROMA

NETHERLANDS

Utrecht
UTRECHT

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
UMC Utrecht - Universitair Medisch Centrum Utrecht
Afdeling Hematologie

NETHERLANDS

Zuid-Holland
ROTTERDAM

Skin Biopsies in Chemotherapy-induced Neuropathy (bortezomib), an observational study
Erasmus MC - Erasmus Medisch Centrum
Afdeling Neurowetenschappen

POLAND

Katowice
GLIWICE

Efficacy and Safety of Double Autologous Hematopoietic Stem Cell Transplantation With Sequential Use of Total Marrow Irradiation and High-dose Melphalan in Multiple Myeloma
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie Oddzial w Gliwicach
Klinika Transplantacji Szpiku i Onkohematologii

POLAND

Katowice
GLIWICE

Safety and Efficacy of Stem Cell Mobilization Using G-CSF (Filgrastim) Alone Compared to Intermediate-dose Cytosine Arabinoside Plus G-CSF in Multiple Myeloma Patients.
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie Oddzial w Gliwicach
Klinika Transplantacji Szpiku i Onkohematologii

SPAIN

Comunidad Valenciana
VALENCIA

SWITZERLAND

Suisse Alémanique
BASEL

Ongoing trial
Expanded Natural Killer (NK) Cells for Multiple Myeloma Study
Universitätsspital Basel
Abteilung Onkologie und Haematologie

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

Multinational clinical trial(s)